Valuation: Kim Forest Enterprise Co., Ltd.

Market Cap 788M 24.75M 21.2M 19.83M 18.16M 34.07M 2.37B 34.52M 234M 91.38M 1.19B 92.92M 90.9M 3.93B P/E 2024
-7.91x
P/E 2025 -7.34x
Enterprise Value 1.05B 32.92M 28.2M 26.38M 24.15M 45.32M 3.15B 45.92M 312M 122M 1.58B 124M 121M 5.23B EV / Sales 2024
2.86x
EV / Sales 2025 2.43x
Free-Float
43.95%
Yield 2024 *
-
Yield 2025 -
1 day+1.16%
1 week-1.51%
Current month-2.25%
1 month-3.33%
3 months+8.75%
6 months-24.78%
Current year-26.27%
1 week 12.7
Extreme 12.7
13.3
1 month 11.75
Extreme 11.75
14.15
Current year 11.4
Extreme 11.4
18.5
1 year 11.4
Extreme 11.4
26.45
3 years 11.4
Extreme 11.4
48.1
5 years 11.4
Extreme 11.4
50.38
10 years 8.27
Extreme 8.27329
122.57
Manager TitleAgeSince
Chief Executive Officer - 01/07/2005
Director of Finance/CFO - 02/12/2013
Chief Tech/Sci/R&D Officer - 01/11/2016
Director TitleAgeSince
Chairman - 22/09/2014
Director/Board Member - 28/07/2004
Director/Board Member - 29/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
+1.16%-1.51%-32.90%-68.02% 24.75M
+0.70%+1.41%-38.41%-41.41% 631M
-7.78%-15.50%+82.52% - 341M
-12.62%-1.82%-29.87%-2.91% 137M
-5.21%-16.89%-23.53%+19.74% 71.13M
Average -4.75%-6.94%-8.44%-23.15% 241.07M
Weighted average by Cap. -3.55%-4.89%-2.19%-31.04%

Financials

2024 2025
Net sales 502M 15.75M 13.49M 12.62M 11.56M 21.69M 1.51B 21.97M 149M 58.16M 757M 59.14M 57.85M 2.5B 549M 17.25M 14.77M 13.82M 12.65M 23.75M 1.65B 24.06M 163M 63.68M 829M 64.75M 63.35M 2.74B
Net income -160M -5.02M -4.3M -4.02M -3.68M -6.91M -480M -7M -47.54M -18.54M -241M -18.85M -18.44M -798M -146M -4.6M -3.94M -3.69M -3.37M -6.33M -440M -6.42M -43.55M -16.98M -221M -17.27M -16.89M -731M
Net Debt 147M 4.6M 3.94M 3.69M 3.38M 6.33M 440M 6.42M 43.57M 16.99M 221M 17.28M 16.9M 731M 260M 8.17M 7M 6.55M 5.99M 11.25M 782M 11.4M 77.36M 30.17M 393M 30.67M 30.01M 1.3B
Logo Kim Forest Enterprise Co., Ltd.
KIM FOREST ENTERPRISE CO., LTD. is a Taiwan-based company mainly engaged in sale of biomedical products and provision of genetic testing and analysis services. The Company operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.
Employees
-
Date Price Change Volume
21/08/26 TWD 13.05 +1.16% 6,202
20/08/26 TWD 12.90 +1.57% 10,674
19/08/26 TWD 12.70 -1.17% 12,799
18/08/26 TWD 12.85 -3.38% 18,499
17/08/26 TWD 13.30 +0.38% 6,630
  1. Stock Market
  2. Stocks
  3. 6645 Stock